肺表面活性物质
片状颗粒
肺
急性呼吸窘迫综合征
呼吸窘迫
肺炎
肺顺应性
表面张力
呼吸系统
表面活性蛋白D
化学
免疫学
微生物学
医学
病理
生物
先天免疫系统
内科学
免疫系统
生物化学
麻醉
物理
量子力学
出处
期刊:PubMed
日期:2002-04-01
卷期号:50 (4): 365-9
摘要
Lung surfactant(LS) is a mixture of several lipids and four apolipoproteins(SP-A, -B, -C and -D) and lowers surface tension at air-liquid interface of alveoli. Most of LS is synthesized and secreted by alveolar type II cells. Although lamellar bodies are storage granules of LS, each component appears to take independent intracellular routes to reside in the granules. Patients with infantile respiratory distress syndrome(IRDS) or acute respiratory distress syndrome(ARDS) develop fatal respiratory failure due to lack of LS. In addition, acute phase of interstitial pneumonia also shows deterioration of LS and increased alveolar surface force resulting in decreased lung compliance. SP-A and SP-D are used as serum marker to evaluated activity of interstitial lung diseases. Recently, growing evidences are accumulating that LS plays a role in innate host defense in the lung against large species of bacteria, mycoplasma, and viruses.
科研通智能强力驱动
Strongly Powered by AbleSci AI